Vir Biotechnology, Inc. VIR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| Grant revenue | $810K-87.7% | $2.04M-80.6% | $2.82M-83.0% | $4.61M-78.3% | $6.56M-81.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Vir Biotechnology, Inc. break its business down?
- Vir Biotechnology, Inc. (VIR) reports total revenues by product across 3 parts — Grant revenue, License and collaboration revenue and Other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Vir Biotechnology, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Vir Biotechnology, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
